Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin Zhang

Showing results (261-270 of 373) with videos related to

Pageof 38
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 10, 2008
[Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer]Wei-Hua Wu, Qing Li, Bing-He Xu, et al.
Medicine|May 6, 2016
Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese PopulationJiayu Wang, Die Sang, Binghe Xu, et al.
Medcomm|December 1, 2025
High-Plex Digital Spatial Profiling Identified Prolactin-Induced Protein mRNA Associated With Response and Survival of Everolimus and Letrozole Treatment for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerYuhang Han, Danyang Ji, Yujing Tan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 22, 2011
CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosisXiaodong Han, Zhenqian Wu, Jianzhong Di, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 26, 2007
[Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth]Pin Zhang, Li-ning Zhang, Fa-liang Zhu, et al.
Frontiers in Neurology|May 1, 2023
Targeted metabolomics reveals serum changes of amino acids in mild to moderate ischemic stroke and stroke mimicsShuxin Tao, Xinxing Xiao, Xin Li, et al.
Endocrine|August 31, 2020
High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumourYitao Gong, Zhiyao Fan, Pin Zhang, et al.
Biomarker Research|February 21, 2023
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studiesXiuwen Guan, Fei Ma, Qiao Li, et al.
Therapeutic Advances in Medical Oncology|September 11, 2024
Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center studyMingxia Jiang, Jiaxuan Liu, Maiyue He, et al.
Medicine|October 30, 2015
Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane TreatmentMeiying Li, Ying Fan, Qing Li, et al.
Pageof 38

Showing results (261-270 of 373) with videos related to

Sort By:
Pageof 38
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 10, 2008
[Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer]Wei-Hua Wu, Qing Li, Bing-He Xu, et al.
Medicine|May 6, 2016
Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese PopulationJiayu Wang, Die Sang, Binghe Xu, et al.
Medcomm|December 1, 2025
High-Plex Digital Spatial Profiling Identified Prolactin-Induced Protein mRNA Associated With Response and Survival of Everolimus and Letrozole Treatment for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerYuhang Han, Danyang Ji, Yujing Tan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 22, 2011
CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosisXiaodong Han, Zhenqian Wu, Jianzhong Di, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 26, 2007
[Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth]Pin Zhang, Li-ning Zhang, Fa-liang Zhu, et al.
Frontiers in Neurology|May 1, 2023
Targeted metabolomics reveals serum changes of amino acids in mild to moderate ischemic stroke and stroke mimicsShuxin Tao, Xinxing Xiao, Xin Li, et al.
Endocrine|August 31, 2020
High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumourYitao Gong, Zhiyao Fan, Pin Zhang, et al.
Biomarker Research|February 21, 2023
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studiesXiuwen Guan, Fei Ma, Qiao Li, et al.
Therapeutic Advances in Medical Oncology|September 11, 2024
Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center studyMingxia Jiang, Jiaxuan Liu, Maiyue He, et al.
Medicine|October 30, 2015
Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane TreatmentMeiying Li, Ying Fan, Qing Li, et al.
Pageof 38